Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Recognize early warning signs of money trouble in your 20s and take decisive steps to protect your financial future.
22,522 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As investors digest Organogenesis (Orgo) 2025 earnings, the focus shifts to revenue mix, profitability, and upcoming ...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...
KAST announces an $80 million Series A led by QED Investors and Left Lane Capital, valuing the stablecoin fintech at ...
When a packaging company posts stronger results, investors take notice. This piece explains why karat packaging stock...
Disney names Josh D’Amaro as CEO, effective March 18, 2026, ending a long succession saga. The new leader brings a un...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
Two tech giants just crossed the earnings finish line, and the market reacted differently. Read how Amazon and Micros...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
CWB blends income with potential equity upside, but its behavior shifts from bond-like to stock-like in market downtu...
A spotlight on KNG shows it earns an 8.6% yield by selling covered calls on Dividend Aristocrats, but eight-year retu...
A fast-growing Brazilian fintech is reshaping personal finance in Latin America. Here are three concrete reasons this...